On the first day of military aggression, pharmacy sales of drugs more than doubled compared to the same day last year, and grew at a high rate in the first 11 days of the war. Currently, sales are declining and show negative growth rates compared to the same period last year, and are lower than in the pre-war period (Fig. 1). This is due not to a decrease in demand, but to a limited number of working pharmacies, their opening hours, limited supplies, a large number of people who went abroad, foreign humanitarian aid, as well as the population stocking up.
In this difficult period, the highest demand among Ukrainians was for drugs treating arterial hypertension, anti-inflammatory and cold remedies, analgesics and antibiotics, diabetes medications, and as evidenced by the volume of unit sales psycholeptic drugs, as well as antiseptics and disinfectants (Fig. 2).
As for the drugs stocks, they were running short because there were certain problems with supply. For some ATC groups of drugs, there were less than 10 days of stock recorded (Fig. 3). Now, the situation with stocks is gradually improving, which is due to the resumption of supplies. For certain groups of drugs, the volume of stocks is higher than in the prewar period, however not all ATC groups of drugs show the same volume of stocks as in the prewar period. It is also necessary to understand that the volume of stock in days directly depends on the volume of consumption, so a decrease in sales volume also affects the increase in the number of days of stock.
However, the situation with the stock of certain drug SKUs remains critical. Our editors analyzed the groups of drugs for which deficits are recorded now, or may be soon. One group of drugs for which a deficiency is already observed is sodium levothyroxine. (Fig. 5). However, on March 25, the Ministry of Health of Ukraine reported that pharmacies began to receive levothyroxine sodium medications, which increased their pharmacy sales and stocks.
It is worth noting that, despite the increased demand for drugs and supply restrictions, there is no significant increase in prices (Fig. 5). However, price growth is still observed. Thus, for the top-10 SKUs by sales volume in monetary terms from 24.02.2022, the average price increase as of 24.04.2022 relative to the prewar period (compared to the price as of 01.02.2022) is 18%. At the same time, the prices have been stabilizing in recent days and stopped growing. We remind that the State Service of Ukraine on Food Safety and Consumer Protection introduced price controls on socially important products, including food, fuel, and medicines.
Also, at the beginning of the military aggression, the volume of sales of medical devices increased significantly, but unit sales have already shown a negative trend (Fig. 6). Which is due to the same factors as for medicines. Currently, sales of medical devices are also lower than in the prewar period.
Among medical devices, the most popular are bandaging materials, nursing items, and products and components used to administer drugs and solutions into tissues and body cavities (Fig. 7). There is also a significant demand for baby care products.
As for the stocks of medical devices, there is a significant decrease in the stocks of bandaging materials, personal care products, and nursing products (Fig. 8). At present, the situation with stocks is stabilizing. For certain groups of drugs, the volume of stocks is higher than in the prewar period. However, the stocks of certain subcategories of medical devices have not returned to the prewar period yet.
Despite difficult circumstances, we continue to inform you about the state of the pharmaceutical market.
**Sorting by sales volumes since 24.02.2022